These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

846 related items for PubMed ID: 16264227

  • 21. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
    Qiu X, Zhang L, Lu S, Song Y, Lao Y, Hu J, Fan H.
    Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
    [Abstract] [Full Text] [Related]

  • 22. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N, Oka M, Yamada-Okabe H, Hamada K, Nakayama H, Mori N, Tamesa T, Okada T, Takemoto N, Matoba K, Takashima M, Sakamoto K, Tangoku A, Miyamoto T, Uchimura S, Hamamoto Y.
    Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
    [Abstract] [Full Text] [Related]

  • 23. Distinctive gene expression profiles associated with Hepatitis B virus x protein.
    Wu CG, Salvay DM, Forgues M, Valerie K, Farnsworth J, Markin RS, Wang XW.
    Oncogene; 2001 Jun 21; 20(28):3674-82. PubMed ID: 11439330
    [Abstract] [Full Text] [Related]

  • 24. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z.
    Cell Signal; 2013 May 21; 25(5):1037-43. PubMed ID: 23376496
    [Abstract] [Full Text] [Related]

  • 25. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 21; 29(3):166-70. PubMed ID: 17649629
    [Abstract] [Full Text] [Related]

  • 26. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.
    Int J Oncol; 2006 Feb 21; 28(2):383-91. PubMed ID: 16391793
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
    Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, Lee CG.
    J Hepatol; 2010 Jul 21; 53(1):57-66. PubMed ID: 20447714
    [Abstract] [Full Text] [Related]

  • 29. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
    Tang S, Hu W, Hu J, Wu S, Li J, Luo Y, Cao M, Zhou H, Jiang X.
    Liver Int; 2015 Feb 21; 35(2):608-19. PubMed ID: 24423280
    [Abstract] [Full Text] [Related]

  • 30. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B, Qian Y, Zhang H, Sang YW, Cheng LF, Wang Q, Gao S, Zheng M, Yao HP.
    World J Gastroenterol; 2016 May 14; 22(18):4538-46. PubMed ID: 27182163
    [Abstract] [Full Text] [Related]

  • 31. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
    Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D.
    Cancer Res; 2001 Nov 01; 61(21):7803-10. PubMed ID: 11691796
    [Abstract] [Full Text] [Related]

  • 32. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI, Lee S, Lee Y, Bong YS, Hyun SW, Yoo YD, Kim SJ, Kim YW, Poo HR.
    Oncogene; 1998 May 07; 16(18):2367-80. PubMed ID: 9620554
    [Abstract] [Full Text] [Related]

  • 33. Hepatitis B virus X protein induced expression of the Nur77 gene.
    Lee MO, Kang HJ, Cho H, Shin EC, Park JH, Kim SJ.
    Biochem Biophys Res Commun; 2001 Nov 16; 288(5):1162-8. PubMed ID: 11700033
    [Abstract] [Full Text] [Related]

  • 34. Repression of hepatitis B virus X gene expression by hammerhead ribozymes.
    Kim YK, Junn E, Park I, Lee Y, Kang C, Ahn JK.
    Biochem Biophys Res Commun; 1999 Apr 21; 257(3):759-65. PubMed ID: 10208856
    [Abstract] [Full Text] [Related]

  • 35. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
    Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L.
    J Med Virol; 2005 Nov 21; 77(3):374-81. PubMed ID: 16173017
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [Abstract] [Full Text] [Related]

  • 37. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis.
    Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q, Zhu HG.
    Exp Mol Pathol; 2010 Dec 15; 89(3):268-75. PubMed ID: 20620135
    [Abstract] [Full Text] [Related]

  • 38. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A.
    Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, Wu Z.
    Cell Signal; 2013 Feb 15; 25(2):439-46. PubMed ID: 23124077
    [Abstract] [Full Text] [Related]

  • 39. Activation of protooncogene c-jun by the X protein of hepatitis B virus.
    Twu JS, Lai MY, Chen DS, Robinson WS.
    Virology; 1993 Jan 15; 192(1):346-50. PubMed ID: 8390762
    [Abstract] [Full Text] [Related]

  • 40. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A, Fujita K, Iwama H, Chiyo T, Fujihara S, Oura K, Tadokoro T, Mimura S, Nomura T, Tani J, Yoneyama H, Kobayashi K, Kamada H, Guan Y, Nishiyama A, Okano K, Suzuki Y, Himoto T, Shimotohno K, Masaki T.
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G401-G409. PubMed ID: 31905024
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.